The commercial teams of pharmaceutical companies are looking for more data analytics and business insights and they’re willing to spend more money to do it. Those are some of the findings of a recent ...
Big data analysis is an invaluable resource in healthcare and life sciences. Data can tell a pharmaceutical company which drugs a medical specialist prescribes and where they are based. This knowledge ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--REALM IDx announced today the launch of REALM Pharma Services, an end-to-end discovery, translational research, and clinical trial service for biotechnology and ...
Zymo Research Corporation and BluMaiden Biosciences are joining forces to offer end-to-end clinical trial analytics and reporting services based on the human microbiome. This partnership is poised to ...
Life sciences commercial teams are drowning in data complexity. Despite having access to sophisticated analytics platforms, teams still spend days navigating multiple dashboards, waiting for insights, ...
The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...
When Zuellig Pharma saw the lack of advanced analytics and trusted data platforms in the healthcare sector, it built an offering it believes can plug the gaps and help pharmaceutical companies enhance ...
The pharmaceutical industry is undergoing a seismic transformation, driven by the integration of data science and analytics. As the demand for novel therapies and personalized medicine surges, leaders ...
Doron Aspitz is the CEO of Verix, a leading provider of AI commercial operations enhancement platforms for the pharmaceutical industry. As the poet once said, “Two paths diverged in a yellow wood,” ...
thesun.ng on MSN
Ogayemi counsels on how data analytics can tackle fake drugs, drive pharmaceutical market access
By Seyi BabalolaCaroline Ogayemi, a pharmacist and recognized data expert, has highlighted the transformative power of data analytics in reshaping pharmaceutical sales and combating counterfeit drugs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results